Centre for Biomedicine & Society, King's College London, Strand, London, UK.
Health (London). 2010 Jan;14(1):41-56. doi: 10.1177/1363459309347477.
This article reports from a study exploring the social processes, meanings and institutions that frame and produce 'ethical problems' and clinical dilemmas for practitioners, scientists and others working in the specialty of preimplantation genetic diagnosis (PGD). A major topic in the data was that, in contrast to IVF, the aim of PGD is to transfer to the woman's womb only those embryos likely to be unaffected by serious genetic disorders; that is, to produce 'healthy babies'. Staff described the complex processes through which embryos in each treatment cycle must meet a double imperative: they must be judged viable by embryologists and 'unaffected' by geneticists. In this article, we focus on some of the ethical, social and occupational issues for staff ensuing from PGD's double imperative.
本文报道了一项研究，该研究探讨了社会过程、意义和制度，这些过程、意义和制度构成并产生了从业者、科学家和其他从事植入前遗传诊断（PGD）专业工作的人所面临的“伦理问题”和临床困境。数据中的一个主要主题是，与体外受精（IVF）不同，PGD 的目的是仅将那些可能不受严重遗传疾病影响的胚胎转移到女性子宫中；也就是说，要生出“健康的婴儿”。工作人员描述了胚胎在每个治疗周期中必须通过的复杂过程，必须通过胚胎学家判断其是否具有活力，并且必须通过遗传学家判断其是否不受遗传疾病影响。在本文中，我们重点介绍了 PGD 的双重指令给工作人员带来的一些伦理、社会和职业问题。
